Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy ; volume:31 ; number:2 ; day:4 ; month:2 ; year:2023 ; pages:1-9 ; date:2.2023
Supportive care in cancer ; 31, Heft 2 (4.2.2023), 1-9, 2.2023
- Creator
-
Nara, Katsuhiko
Yamamoto, Takehito
Sato, Yasuyoshi
Yagi, Koichi
Kawasaki, Koichiro
Toriumi, Tetsuro
Takada, Tappei
Seto, Yasuyuki
Suzuki, Hiroshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-07609-6
- URN
-
urn:nbn:de:101:1-2023041610110022871515
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nara, Katsuhiko
- Yamamoto, Takehito
- Sato, Yasuyoshi
- Yagi, Koichi
- Kawasaki, Koichiro
- Toriumi, Tetsuro
- Takada, Tappei
- Seto, Yasuyuki
- Suzuki, Hiroshi
- SpringerLink (Online service)
Other Objects (12)
Febrile neutropenia : with 32 tables
Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
Febrile neutropenia : with 32 tables
Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
Febrile neutropenia : with 32 tables
Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia